An interventional study of Saline (0.9%, sterile, for infusion) and Norepinephrine in Emergency Surgery and Hypotension (MeSH: D007022), sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Cairo University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Hypotension by Cairo University — 10 open to participants now, 10 under way, 1 of them phase 3. Hypotension · Cairo University.
Among the 33 studies in Hypotension by Cairo University, this one is the 10th largest by planned enrollment of the 19 interventional ones that give a count, is one of 6 that started in 2026, is one of 14 with no phase, and was the 33rd registered.
893 studies on the registry are indexed under Hypotension; 197 are open to participants now.
Browse Hypotension studies →10 of the 33 studies in Hypotension by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 21–65
Cairo University · Sites in Egypt
Ages 50+
Cairo University · Sites in Egypt
Ages 18–40 · Women only
Cairo University · Sites in Egypt
Ages 21–65
Cairo University · Sites in Egypt
Ages 60+
By country, each count listing its studies:
Of the 112 Hypotension studies recruiting now, 51 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 86 across 592 interventional studies indexed under Hypotension.
Median enrollment 100 across the 19 interventional studies, 69 across the 14 observational. Of the 20 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,965 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
4 of the studies in Hypotension by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07379710Cairo UniversityNorepinephrine With Ephedrine Versus Norepinephrine Alone During Spinal Anesthesia for Cesarean Delivery | 2026-12 |
| NCT07722013Cairo UniversityIntermittent Ephedrine Boluses for Prophylaxis Against Postinduction Hypotension | 2026-12 |
| NCT07719075Cairo University5 Versus 10 mcg Norepinephrine Bolus in Treatment of Postinduction and Early Intraoperative Hypotension in Emergency Abdominal Surgery | 2026-12 |
| NCT07949890Cairo UniversityTitrated Norepinephrine for Prophylaxis Against Intraoperative Hypotension in Emergency Surgery | 2027-06 |
Add all 4 to your calendar (.ics) → With an account.
Among the 33 studies in Hypotension by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A titrated approach, initiating norepinephrine infusion only when non invasive mean arterial (MAP) falls below 75 mmHg, may provide more balanced hemodynamic control and reduce the risk of hypertension.
To the best of our knowledge, no studies have specifically evaluated prophylactic vasopressor use in patients undergoing emergency surgery for septic source control. In this study, we investigate the efficacy of titrated norepinephrine infusion as a prophylactic strategy against intraoperative hypotension in emergency surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
saline infusion
Drug: Saline (0.9%, sterile, for infusion)
norepinephrine infusion
Drug: Norepinephrine
500 mL of normal saline will be used without the addition of any drug. The managing anesthetist will withdraw the solution into a 50 mL syringe. When intraoperative mean arterial pressure (MAP) decreases to less than MAP 75 mmHg, saline will be infused at a rate of 0.75 mL/kg/h
4000 mcg of norepinephrine will be diluted in 500 mL of normal saline to yield a final concentration of 8 mcg/mL. The managing anesthetist will withdraw the solution into a 50 mL syringe. When intraoperative mean arterial pressure (MAP) decreases to less than MAP 75 mmHg, the prepared norepinephrine will be infused at a rate of 0.75 mL/kg/h
incidence of intraoperative hypotension
MAP \<65 mmHg or \< 70 % of baseline
Time frame: immediately after induction of anesthesia until extubation
Area under a MAP of 65 mmHg
Time frame: immediately after induction of anesthesia until extubation
serum lactate
Time frame: 30 minutes after extubation
acute kidney injury
Time frame: 24 hours after surgery
delirium
by Confusion Assessment Method (CAM) score
Time frame: 24 hours after surgery
Plan to share: No — The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Jun 2027, 6 months later.
Of 212 non-industry interventional studies with no phase under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 22. This study's planned 6 months is below that.
Counting every sponsor, half of 219 studies reached it within 12 months; a quarter within 6 and three quarters within 22.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.